Glucose monitor study in gestational diabetes pulled before starting
NCT ID NCT06490874
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 31 times
Summary
This study was designed to compare blood sugar patterns using continuous glucose monitors in pregnant women with gestational diabetes who were treated with either metformin or insulin. Researchers planned to enroll 300 participants and track glucose levels during pregnancy and for two years after delivery. The study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY, HIGH RISK are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Premier Health - Miami Valley Hospital
Dayton, Ohio, 45409, United States
-
The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine
Columbus, Ohio, 43210, United States
-
University of Alabama
Tuscaloosa, Alabama, 35487, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Continuous glucose monitor (CGM) device
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.